阳性淋巴结数量在预测腮腺黏液表皮样癌预后方面优于第8版AJCC颈部分期
该回顾性研究纳入720例接受颈淋巴结清扫的腮腺黏液表皮样癌患者,评估阳性淋巴结数量等淋巴结因素与总生存的关系。结果显示,出现2枚阳性淋巴结前生存未进一步受损;调整阳性淋巴结数量后,腮腺内淋巴结转移、淋巴结大小和结外延伸与预后无关。基于转移淋巴结数量提出的N分期(0/1 vs 2-4 vs 5+)在总生存预测上C指数优于AJCC N分期。
要点
- 出现2枚阳性淋巴结前,总生存未见进一步受损。
- 调整阳性淋巴结数量后,腮腺内淋巴结转移、结外延伸和淋巴结大小与预后无关。
- 基于转移淋巴结数量的N分期(0/1 vs 2-4 vs 5+)对总生存的区分能力优于AJCC N分期。
核心结论
- 定量淋巴结负荷是预后的重要决定因素,所提出的N分期在总生存分层上优于AJCC N分期。
研究设计与样本
- 回顾性纳入接受颈淋巴结清扫的腮腺黏液表皮样癌患者,共720例,平均年龄56±16岁;主要结局为总生存(OS)。
主要发现
- 出现2枚阳性淋巴结前,总生存未见进一步受损。
- 调整阳性淋巴结数量后,腮腺内淋巴结转移、结外延伸和淋巴结大小与预后无关。
- 基于转移淋巴结数量的N分期(0/1 vs 2-4 vs 5+)在总生存预测上的C指数优于AJCC N分期。
关键数值与推荐
- 所提出的N分期按阳性淋巴结数量分为0/1、2-4、5+三组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To clarify the impact of the number of positive lymph nodes (LNs) on the prognosis of parotid mucoepidermoid carcinoma (MEC). METHODS: Patients who underwent neck dissection for parotid MEC were retrospectively enrolled. The primary outcome variable was overall survival (OS). Associations between OS and LN factors, including the AJCC N stage, intraparotid LN metastasis, number of positive LNs, LN size, and extranodal extension (ENE), were evaluated using Cox proportional hazard regression analyses. RESULTS: A total of 720 patients were included with a mean age of 56 ± 16 years. There was no additional survival compromise until two positive LNs were presented. After adjusting for the number of positive LNs, intraparotid LN metastasis, ENE, and LN size were not related to prognosis. Our proposed N stage based on the number of metastatic LNs (0/1 vs. 2-4 vs. 5+) showed a superior C-index to the AJCC N stage in OS prediction. CONCLUSION: Quantitative LN burden was an important determinant of prognosis, and the proposed N stage provided better OS stratification than the AJCC N stage.
引用
- Li W, Yu W, Cao H, et al. Number of positive lymph nodes is superior to neck stage of the 8th AJCC in predicting prognosis in parotid mucoepidermoid carcinoma. Head Neck. 2023. PMID: 37594176. doi:10.1002/hed.27486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。